Risa Shorr
- Genetics top 5%
- Mesenchymal stem cell research 12
- Oncology top 5%
- CAR-T cell therapy research 8
- Pancreatic and Hepatic Oncology Research 5
- Internal Medicine top 5%
- Venous Thromboembolism Diagnosis and Management 7
- Hematology top 5%
- Hematopoietic Stem Cell Transplantation 12
- Biochemistry top 10%
- Blood transfusion and management 8
-
- Chemotherapy-related skin toxicity 6
-
- Health Systems, Economic Evaluations, Quality of Life 5
- Co-authors
- David AllanBrian HuttonDean FergussonCarmel JacobsMark ClemonsSasha MazzarelloManoj M. LaluAdrian Bailey
- Cited by
- GeneticsOncologyInternal Medicine
- Partner nations
- CanadaUnited StatesUnited Kingdom
In The Last Decade
Risa Shorr
129 papers receiving 1.8k citations
Peers
Comparison fields: 5 of 135
- Genetics 270
- Oncology 552
- Internal Medicine 67
- Hematology 151
- Biochemistry 74
Countries citing papers authored by Risa Shorr
This map shows the geographic impact of Risa Shorr's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Risa Shorr with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Risa Shorr more than expected).
Fields of papers citing papers by Risa Shorr
This network shows the impact of papers produced by Risa Shorr. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Risa Shorr. The network helps show where Risa Shorr may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Risa Shorr, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2025 | 0 | |
| 3 | 2025 | 0 | |
| 4 | 2024 | 2 | |
| 5 | 2023 | 4 | |
| 6 | 2022 | 9 | |
| 7 | 2022 | 32 | |
| 8 | 2022 | 13 | |
| 9 | 2022 | 3 | |
| 10 | 2021 | 9 | |
| 11 | 2021 | 10 | |
| 12 | 2021 | 8 | |
| 13 | 2021 | 27 | |
| 14 | 2020 | 4 | |
| 15 | 2020 | 16 | |
| 16 | 2020 | 51 | |
| 17 | 2019 | 18 | |
| 18 | 2017 | 6 | |
| 19 | 2017 | 20 | |
| 20 | 2016 | 22 |
About Risa Shorr
Risa Shorr is a scholar working on Medical Terminology, Internal Medicine and Hematology, having authored 136 papers that have together received 1.9k indexed citations. Recurring topics across this work include Hematopoietic Stem Cell Transplantation (12 papers), Mesenchymal stem cell research (12 papers), Blood transfusion and management (8 papers), CAR-T cell therapy research (8 papers), Venous Thromboembolism Diagnosis and Management (7 papers), Chemotherapy-related skin toxicity (6 papers), Pancreatic and Hepatic Oncology Research (5 papers) and Health Systems, Economic Evaluations, Quality of Life (5 papers). The work is most often cited by research in Genetics (270 citations), Oncology (552 citations) and Internal Medicine (67 citations). Risa Shorr has collaborated with scholars based in Canada, United States and United Kingdom. Frequent co-authors include David Allan, Brian Hutton, Dean Fergusson, Carmel Jacobs, Mark Clemons, Sasha Mazzarello, Manoj M. Lalu, Adrian Bailey, Mohammed Ibrahim and Terry L. Ng. Their work appears in journals such as BMJ Open, PLoS ONE, Cytotherapy, Systematic Reviews and Breast Cancer Research and Treatment.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.